Audited Results of Jubilant Pharmova Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	263.50	745.70	784.70	810.12	87.75
Manufacturing Expenses	26.20	78	68.40	75.37	9.27
Personnel Expenses	103.80	203	190	167.27	49.21
Selling Expenses	1.20	3.80	3	1.43	0.33
Administrative Expenses	83.50	133.70	128.50	148.26	35.72
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	214.70	713.60	768.20	806.89	94.53
Operating Profit	48.80	32.10	16.50	3.23	-6.79
Other Recurring Income	2.40	99.60	103.40	137.89	125.87
Adjusted PBDIT	51.20	131.70	119.90	141.12	119.08
Financial Expenses	7.30	29.80	29.90	18.52	30.59
Depreciation	6	53.10	48.30	43.25	6.25
Other Write offs	0	0	0	0	0
Adjusted PBT	37.90	48.80	41.70	79.34	82.25
Tax Charges	9.30	18.40	10.10	29.46	3.75
Adjusted PAT	28.60	30.40	31.60	49.88	78.50
Non Recurring Items	34.10	-11.50	-0.20	-0.77	0.25
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	63.20	19.20	31.60	49.88	78.50
Equity Dividend	79.60	79.60	79.60	79.64	79.64
Preference Dividend	0	0	0	0	0
Retained Earnings	1,001.60	1,014.90	1,075.40	1,123.50	1,154.03

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article